Propel Bio Management »

Fulcrum Therapeutics shares owned by Propel Bio Management

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $4.7M 750k 6.20
2024-03-31 $7.1M 750k 9.44
2023-12-31 $5.1M 750k 6.75